medindia
  1. Medindia
  2. Health Tips and Quotations

FDA Approved Combination Treatment for Acute Myeloid Leukemia (AML)

The United States Food and Drug Administration has recently approved the use of Midostaurin (Rydapt) drug along with chemotherapy for treating patients with acute myeloid leukemia (AML), with a specific gene mutation called FLT3 (FMS-like tyrosine kinase 3).

FDA approves combination treatment for acute myeloid leukemia (AML) - Acute myeloid leukemia (AML) is a tyoe of cancer in the bone marrow - Midostaurin drug is used along with chemotherapy for treating AML

Midostaurin and Chemotherapy Combination Approved by FDA for Acute Myeloid Leukemia Treatment

The United States Food and Drug Administration has approved the use of midostaurin drug along with chemotherapy for acute myeloid leukemia treatment. Read More

Related Links

Slim Down Naturally With Ash Gourd Juice
Do You Get Drowsy At Work After Having Lunch?
Eating Right at Night: Choosing the Best Foods for Evening Health
Menopause and Heart Health: Protecting Your Cardiovascular Wellness
Savor Strawberries Everyday to Keep Dementia at Bay
High-Protein Breakfast: Your Path to Body Fat Loss
Why Does Foot Swelling Occur While Flying?
Mood Foods: What to Eat and What to Avoid for Better Mental Health
Men's Health Signals You Should Not Ignore
Top 5 Everyday Habits That Affect Your Vision
Harness the Healing Power of Avocado Seed Tea
Nutritional Guide to Staying Healthy During the Monsoon Season

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024